Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

450
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
450
Impression Management Techniques I: Managing Appearances01:29

Impression Management Techniques I: Managing Appearances

227
Appearance is a multidimensional aspect of self-presentation that encompasses observable attributes such as clothing, grooming, speech, and nonverbal behavior. These elements are often strategically managed to align with socially constructed expectations in different settings. For instance, individuals tailor their appearance during job interviews, social gatherings, or athletic events to meet the perceived norms of those environments.Contextual Adaptation and Social SignalsThe research...
227
Managing Impressions01:19

Managing Impressions

178
Impression management encompasses individuals' deliberate efforts to shape how others perceive them during social interactions. This behavior is often employed to conform to social norms, secure approval, or pursue specific goals. While it involves selective self-presentation, it is not necessarily deceptive; individuals frequently present authentic aspects of themselves that align with situational demands.Common strategies include:Ingratiation: where individuals use flattery or agreeableness...
178
Management of Insomnia01:19

Management of Insomnia

684
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
684
Angina IV: Management01:26

Angina IV: Management

309
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
309
Angina V: Nursing Management01:20

Angina V: Nursing Management

358
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
358

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Active palliative anti-cancer therapy.

International journal of palliative nursing·2018
See all related articles

Related Experiment Video

Updated: Feb 15, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

14.1K

Patient management and docetaxel.

Val Aston1

  • 1Chemotherapy Nurse Specialist, Velindre NHS Trust, Whitchurch, Cardiff, UK.

International Journal of Palliative Nursing
|January 12, 2018
PubMed
Summary
This summary is machine-generated.

New docetaxel (Taxotere®) chemotherapy offers significant disease responses and symptom relief for advanced breast cancer patients. Its manageable side effects make it suitable for outpatient settings, with practical guidance provided for handling them.

More Related Videos

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
06:43

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management

Published on: November 21, 2017

25.1K
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.2K

Related Experiment Videos

Last Updated: Feb 15, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

14.1K
Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
06:43

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management

Published on: November 21, 2017

25.1K
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.2K

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Advanced breast cancer presents significant treatment challenges.
  • Docetaxel (Taxotere®) is a potent chemotherapeutic agent with potential for disease response and palliation.

Purpose of the Study:

  • To describe early clinical experience with docetaxel in an outpatient setting.
  • To provide practical guidance on managing docetaxel-induced toxicities.

Main Methods:

  • Retrospective review of early cases treated with docetaxel.
  • Observation of patient responses and side effect profiles.
  • Development of management strategies for toxicities.

Main Results:

  • Docetaxel demonstrated significant disease responses and symptom palliation in advanced breast cancer.
  • Observed toxicities were generally predictable, manageable, and reversible.
  • The drug proved suitable for administration in a nurse-assisted day case chemotherapy clinic.

Conclusions:

  • Docetaxel represents a valuable therapeutic option for advanced breast cancer, improving patient outcomes.
  • Effective management of side effects facilitates outpatient use, enhancing patient convenience and care.
  • Early clinical experience supports the integration of docetaxel into standard chemotherapy protocols.